[Anticoagulation in stroke. Evidence-based and empirical indications].
Walter
U
U
Klinik und Poliklinik für Neurologie, Universität Rostock. uwe.walter@med.uni-rostock.de
Kloth
A
A
Benecke
R
R
Kunesch
E
E
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D002986:Clinical Trials as Topic; D000075202:Contraindications; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006496:Heparinoids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D010314:Partial Thromboplastin Time; D010919:Placebos; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011322:Primary Prevention; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012307:Risk Factors; D012737:Sex Factors; D020521:Stroke / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D010919:Placebos; D010975:Platelet Aggregation Inhibitors; D006493:Heparin